FAPI PET/MR imaging for glioblastoma
Part of Cancer clinical trials.
This study uses a special PET/MR scan to look at certain cells called cancer-associated fibroblasts in glioblastoma brain tumors. It aims to see if this imaging approach can better detect tumors or their recurrence, helping guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a brain lesion that doctors suspect is a glioblastoma (either new or coming back).
- You are able to do most daily activities (ECOG score 0–3).
- You are not pregnant or breastfeeding.
- You do not have severe claustrophobia that would stop you from having a scan.
- You are not allergic to the study tracer (FAPI) or gadolinium contrast agents used in MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan (FAPI-PET) during routine workup to help detect tumors and decide how far they may have spread. You may be able to take part if you need a staging or restaging scan and can safely complete the imaging.
This study uses a special type of PET/CT scan (FAPI) to get a better look at the environment around colorectal cancer that has spread to the liver. It may help doctors learn more about the tumor and plan treatment.
This trial tests a new imaging method (FAPI PET/MRI) to see if it can help evaluate breast cancer. It focuses on people with invasive breast cancer who are about to start treatment before surgery or who have recurrent or new breast cancer.
This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.
This study tests how useful a special PET/CT scan (called 68Ga-FAPI) is for people who may have or have been diagnosed with cancer. The scan may help doctors see cancer activity more clearly.
This study tests a new type of PET scan that uses a special tracer called FAPI to find where cancer has spread in your body. It may help doctors see hidden tumors more clearly without needing extra treatments first.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.